Portfolio Update

RNS Number : 6631I

Intl. Biotechnology Trust PLC

16 March 2010

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

Portfolio update as at 28 February 2010                                                                                

Total Net Assets	£101.1m
NAV per share	164.1p
Share Price	131.0p
Total value of unquoted investments	£21.6m
Total number of portfolio companies	58
Cash	1%
Cash committed and reserved to unquoted investments	16%
Portfolio companies with < 1 year of cash	9%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	8.91	9,015,659
Celgene	7.24	7,324,706
Amgen	5.85	5,921,628
Gilead Sciences	4.77	4,825,959
Genzyme	4.00	4,048,786
Alexion Pharmaceuticals	3.80	3,847,923
Shire	3.22	3,259,597
EUSA Pharma	2.91	2,942,348
Oxagen	2.88	2,909,479
Insulet	2.88	2,909,429
	-----------	--------------
Total	46.46	47,005,514

Geographical Allocation	%
United States	80
Europe	17
Cash	2
Australia	1
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	78
Unquoted	21
Cash	1
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

16 MARCH 2010

 

END

 

 

PFUBXGDXBXBBGGL